The World Drug Safety Congress Europe is empowering patients, physicians, pharma, biotech and consumers to make the best drug safety decisions.
They will bring together 700+ key thought leaders to explore these challenges within pharmacovigilance.
Explore the use of big data and AI in pharmacovigilance, examine benefit-risk management strategies and patient-centric approaches; discuss how you can tackle the challenges of social media and drug safety legislation globally.
Addressing Key Challenges for Safety Professionals
The World Drug Safety Congress Europe is set to bridge the gap between international regulatory bodies, industry professionals and academic representatives and will address how to drive pharmacovigilance operations forward.
World Drug Safety Focuses On
✓ How to plan for the wider international drug safety landscape
✓ How to work compliantly with a global regulatory overview and recent developments
✓ How to establish a robust approach to safety in oncology and advanced therapies
✓ How to harness Big Data and emerging technologies such as AI to support your safety measures
✓ How to manage drug safety operations in light of increasing complexities
✓ How to manage data and electronic submissions better
✓ How to effectively process the volume of cases
✓ How to operate within financial and logistical constraints
Agenda
Curious about the speakers during this conference? Check what both days will look like here!
Practical information
World Drug Safety Congress Europe 2022
27 - 29 September
RAI Congress Centre, Amsterdam
NB: If you get your tickets before the 2nd of September, you get discount!
Source: World Drug Safety Congress